Skip to content
Search

Latest Stories

Protect Britain could help NHS save billions of pounds a year: Tony Blair Institute

Protect Britain could help NHS save billions of pounds a year: Tony Blair Institute

The separate organisation should be responsible for identifying patients who need pre-emptive treatment

Former UK prime minister, Tony Blair has expressed that there should be a dedicated prevention organisation to identify people who need pre-emptive treatment, health advice and weight-loss drugs, The Times reported.


The Tony Blair Institute argued that this could save the NHS billions of pounds a year and boost the economy.

About 40 per cent of the health service’s budget is used on treating preventable conditions, with obesity costing £19 billion a year, as estimated by the institute.

Blair’s think tank has suggested that a separate organisation, Protect Britain, should work along with the NHS to identify at-risk patients, who should also be given exercise and diet advice as well as effective weight-loss drugs such as Novo Nordisk's Wegovy.

Using AI, medical records could be analysed to find out which patients may benefit from which preventive treatments, it stated, as reported by the publication.

The organisation could use existing methods such as texts and phone calls, and publicity campaigns to make people aware of the preventable conditions, it added.

Further, the institute argued that the NHS app should be revamped to alert people to treatments and tests they need to undergo.

Earlier, Labour's shadow health secretary Wes Streeting had also shared plans expand use of the NHS app to alert patients eligible for vaccination and screening.

The World Health Organization (WHO)’s 2022 estimates showed that obesity affects over 1 billion people worldwide, including 650 million adults, 340 million adolescents and 39 million children.

Unfortunately, this number is still increasing, and WHO estimates that approximately 167 million people will become less healthy by 2025, because of excess weight.

Too much weight can cause harm to the patient’s heart, liver, kidneys, joints and reproductive system, and make them prone to a range of noncommunicable diseases (NCDs), such as type 2 diabetes, cardiovascular disease, hypertension and stroke, certain cancers, as well as mental health issues.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less